Study Summary
This trial is testing whether a systemic-to-pulmonary artery shunt or ductal artery stent is better for treating babies with ductal-dependent pulmonary blood flow.
- Congenital Heart Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: 1 year
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Ductal Artery Stent
1 of 2
Systemic-to-Pulmonary Artery Shunt
1 of 2
Experimental Treatment
300 Total Participants · 2 Treatment Groups
Primary Treatment: Systemic-to-Pulmonary Artery Shunt · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 1 - 30 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Might I be qualified to participate in this medical study?
"This clinical trial is enrolling 300 neonates, who are no older than 30 days of age and have Congenital Heart Disease. Optimally, these infants require only a stable pulmonary circulation to be palliated: either through Ductal-Associated Stenting (DAS) or by Surgical Pulmonary Shunt Placement (SPS)." - Anonymous Online Contributor
How many healthcare facilities are actively participating in this research endeavor?
"The list of participating medical centres in this clinical trial includes New York Presbyterian Hospital/Columbia University Irving Medical Center, Children's Hospital Los Angeles, and the University of Alabama at Birmingham. Additionally, there are 25 other clinics facilitating enrollment across the United States." - Anonymous Online Contributor
What is the scope of participation in this experiment?
"This clinical trial requires 300 eligible patients to partake in the research. Those interested may sign up at New York Presbyterian Hospital/Columbia University Irving Medical Center located in New York, NY and Children's Hospital Los Angeles based out of California." - Anonymous Online Contributor
Are senior citizens eligible for inclusion in this research?
"The target demographic of this experiment are individuals between 1 Day and 30 Days years old." - Anonymous Online Contributor
Are there any opportunities for participation in this experiment at the moment?
"Clinicaltrials.gov reveals that this trial is still in progress, with the original post date being June 2nd 2022 and the most recent edit on November 21st of the same year." - Anonymous Online Contributor